OBJECTIVE: To define the relative frequencies of different mechanisms of viral escape. DESIGN: A population-based approach to examine the distribution of HIV polymorphism associated with diverse population human leucocyte antigens (HLAs) at sites within and flanking CD8 T-cell epitopes as a correlate of likely mechanisms of viral escape. METHODS: Sequence windows surrounding 874 HLA allele-specific polymorphisms across the full HIV-1 proteomic consensus sequence were scanned by an epitope-prediction programme. Either already known or probable CD8 T-cell epitopes with HLA restriction matching that of the proximal HLA association were identified and synthesized. These peptides were used as stimulating antigens in automated enzyme-linked immunospot (ELISpot) assays. Peptide arrays were customized to each individual based on their HLA genotype. RESULTS: Among HLA-associated HIV polymorphisms detected in the viral sequences of a cohort of 800 individuals with chronic subtype B HIV infection, those which were likely to affect HLA peptide binding were significantly more common than polymorphisms at nonanchor HLA binding sites. HIV epitopes with such polymorphisms were associated with reduced IFNγ responses in ELISpot assays. HIV escape at sites affecting T-cell receptor (TCR) engagement and epitope processing were also evident. CONCLUSION: HIV escape from HLA-peptide binding predominates as an effective viral evasion strategy and therefore has implications for inclusion of HLA-adapted epitopes in vaccine immunogens.
OBJECTIVE: To define the relative frequencies of different mechanisms of viral escape. DESIGN: A population-based approach to examine the distribution of HIV polymorphism associated with diverse population human leucocyte antigens (HLAs) at sites within and flanking CD8 T-cell epitopes as a correlate of likely mechanisms of viral escape. METHODS: Sequence windows surrounding 874 HLA allele-specific polymorphisms across the full HIV-1 proteomic consensus sequence were scanned by an epitope-prediction programme. Either already known or probable CD8 T-cell epitopes with HLA restriction matching that of the proximal HLA association were identified and synthesized. These peptides were used as stimulating antigens in automated enzyme-linked immunospot (ELISpot) assays. Peptide arrays were customized to each individual based on their HLA genotype. RESULTS: Among HLA-associated HIV polymorphisms detected in the viral sequences of a cohort of 800 individuals with chronic subtype B HIV infection, those which were likely to affect HLA peptide binding were significantly more common than polymorphisms at nonanchor HLA binding sites. HIV epitopes with such polymorphisms were associated with reduced IFNγ responses in ELISpot assays. HIV escape at sites affecting T-cell receptor (TCR) engagement and epitope processing were also evident. CONCLUSION: HIV escape from HLA-peptide binding predominates as an effective viral evasion strategy and therefore has implications for inclusion of HLA-adapted epitopes in vaccine immunogens.
Authors: Tomer Hertz; David Nolan; Ian James; Mina John; Silvana Gaudieri; Elizabeth Phillips; Jim C Huang; Gonzalo Riadi; Simon Mallal; Nebojsa Jojic Journal: J Virol Date: 2010-11-17 Impact factor: 5.103
Authors: Will Fischer; Simon Perkins; James Theiler; Tanmoy Bhattacharya; Karina Yusim; Robert Funkhouser; Carla Kuiken; Barton Haynes; Norman L Letvin; Bruce D Walker; Beatrice H Hahn; Bette T Korber Journal: Nat Med Date: 2006-12-24 Impact factor: 53.440
Authors: P J Goulder; R E Phillips; R A Colbert; S McAdam; G Ogg; M A Nowak; P Giangrande; G Luzzi; B Morgan; A Edwards; A J McMichael; S Rowland-Jones Journal: Nat Med Date: 1997-02 Impact factor: 53.440
Authors: Jonathan M Carlson; Chanson J Brumme; Eric Martin; Jennifer Listgarten; Mark A Brockman; Anh Q Le; Celia K S Chui; Laura A Cotton; David J H F Knapp; Sharon A Riddler; Richard Haubrich; George Nelson; Nico Pfeifer; Charles E Deziel; David Heckerman; Richard Apps; Mary Carrington; Simon Mallal; P Richard Harrigan; Mina John; Zabrina L Brumme Journal: J Virol Date: 2012-10-10 Impact factor: 5.103
Authors: Mina John; David Heckerman; Ian James; Lawrence P Park; Jonathan M Carlson; Abha Chopra; Silvana Gaudieri; David Nolan; David W Haas; Sharon A Riddler; Richard Haubrich; Simon Mallal Journal: J Immunol Date: 2010-03-15 Impact factor: 5.422
Authors: Corey B Moore; Mina John; Ian R James; Frank T Christiansen; Campbell S Witt; Simon A Mallal Journal: Science Date: 2002-05-24 Impact factor: 47.728
Authors: Sharon A Riddler; Richard Haubrich; A Gregory DiRienzo; Lynne Peeples; William G Powderly; Karin L Klingman; Kevin W Garren; Tania George; James F Rooney; Barbara Brizz; Umesh G Lalloo; Robert L Murphy; Susan Swindells; Diane Havlir; John W Mellors Journal: N Engl J Med Date: 2008-05-15 Impact factor: 91.245
Authors: David W Haas; Grant R Wilkinson; Daniel R Kuritzkes; Douglas D Richman; Janet Nicotera; Laura F Mahon; Cara Sutcliffe; Sue Siminski; Janet Andersen; Kristine Coughlin; Ellen W Clayton; Jonathan Haines; Ann Marshak; Michael Saag; Jody Lawrence; Jeffrey Gustavson; Jo Anne Bennett; Rolf Christensen; Margaret A Matula; Alastair J J Wood Journal: HIV Clin Trials Date: 2003 Sep-Oct
Authors: Rika Draenert; Sylvie Le Gall; Katja J Pfafferott; Alasdair J Leslie; Polan Chetty; Christian Brander; Edward C Holmes; Shih-Chung Chang; Margaret E Feeney; Marylyn M Addo; Lidia Ruiz; Danni Ramduth; Prakash Jeena; Marcus Altfeld; Stephanie Thomas; Yanhua Tang; Cori L Verrill; Catherine Dixon; Julia G Prado; Photini Kiepiela; Javier Martinez-Picado; Bruce D Walker; Philip J R Goulder Journal: J Exp Med Date: 2004-04-05 Impact factor: 14.307
Authors: Nilu Goonetilleke; Michael K P Liu; Jesus F Salazar-Gonzalez; Guido Ferrari; Elena Giorgi; Vitaly V Ganusov; Brandon F Keele; Gerald H Learn; Emma L Turnbull; Maria G Salazar; Kent J Weinhold; Stephen Moore; Norman Letvin; Barton F Haynes; Myron S Cohen; Peter Hraber; Tanmoy Bhattacharya; Persephone Borrow; Alan S Perelson; Beatrice H Hahn; George M Shaw; Bette T Korber; Andrew J McMichael Journal: J Exp Med Date: 2009-06-01 Impact factor: 14.307
Authors: Julia Roider; Tim Meissner; Franziska Kraut; Thomas Vollbrecht; Renate Stirner; Johannes R Bogner; Rika Draenert Journal: Immunology Date: 2014-10 Impact factor: 7.397
Authors: Anna Fuller; Aaron Wall; Michael D Crowther; Angharad Lloyd; Alexei Zhurov; Andrew K Sewell; David K Cole; Konrad Beck Journal: Bio Protoc Date: 2017-07-05
Authors: Sietske Rosendahl Huber; Josine van Beek; Jørgen de Jonge; Willem Luytjes; Debbie van Baarle Journal: Front Immunol Date: 2014-04-16 Impact factor: 7.561
Authors: Victor Y Du; Anju Bansal; Jonathan Carlson; Jesus F Salazar-Gonzalez; Maria G Salazar; Kristin Ladell; Stephanie Gras; Tracy M Josephs; Sonya L Heath; David A Price; Jamie Rossjohn; Eric Hunter; Paul A Goepfert Journal: J Immunol Date: 2016-03-16 Impact factor: 5.422
Authors: Emily Adland; Jonathan M Carlson; Paolo Paioni; Henrik Kløverpris; Roger Shapiro; Anthony Ogwu; Lynn Riddell; Graz Luzzi; Fabian Chen; Thambiah Balachandran; David Heckerman; Anette Stryhn; Anne Edwards; Thumbi Ndung'u; Bruce D Walker; Søren Buus; Philip Goulder; Philippa C Matthews Journal: PLoS One Date: 2013-09-02 Impact factor: 3.240
Authors: Martha Sedegah; Bjoern Peters; Michael R Hollingdale; Harini D Ganeshan; Jun Huang; Fouzia Farooq; Maria N Belmonte; Arnel D Belmonte; Keith J Limbach; Carter Diggs; Lorraine Soisson; Ilin Chuang; Eileen D Villasante Journal: PLoS One Date: 2016-10-03 Impact factor: 3.240